Statin-induced calcific Achilles tendinopathy in rats: comparison of biomechanical and histopathological effects of simvastatin, atorvastatin and rosuvastatin
- 488 Downloads
Accumulating clinical evidence indicates the risk of tendinopathy and spontaneous and/or simultaneous tendon ruptures associated with statin use. This experimental study was designed to evaluate and compare the biomechanical and histopathological effects of the three most commonly prescribed statins (simvastatin, atorvastatin and rosuvastatin) on the Achilles tendon in rats.
Statins were administered by gavage to rats at daily doses of 20 and 40 mg/kg for 3 weeks. One week later, the Achilles tendons were dissected and their biomechanical properties, including ultimate tensile force, yield force and elastic modulus, were determined. The samples were stained with haematoxylin–eosin and examined under a light microscope. The biomechanical properties of the tibia were tested by three-point bending test. Bone mineral density (BMD) and the lengths of tibias were measured by computed tomography.
All the statins caused deterioration of the biomechanical parameters of the Achilles tendon. Histopathological analysis demonstrated foci of dystrophic calcification only in the statin-treated groups. However, the number and the total area of calcific deposits were similar between the statin groups. The biomechanical parameters of tibias were improved in all the statin groups. BMD in the statin-treated groups was not significantly different from the control group.
All the statins tested are associated with calcific tendinopathy risk of which full awareness is required during everyday medical practice. However, statin-associated improvement of bone biomechanical properties is a favourable feature which may add to their beneficial effects in atherosclerotic cardiovascular disease, especially in the elderly.
KeywordsSimvastatin Atorvastatin Rosuvastatin Biomechanics Calcific tendinopathy Achilles tendon Bone density
The funding support from Turkish Society of Orthopaedics and Traumatology (TOTBID) for this work is gratefully acknowledged.
This research project was designed and conducted by F. Kaleağasıoğlu and E. Olcay who also interpreted the data, drafted the paper and revised it critically. V. Olgac conducted and interpreted the pathological analysis.
Compliance with ethical standards
Conflict of interest
The authors declare that there are no conflicts of interest.
- 12.Finegold JA, Manisty CH, Goldacre B, Barron AJ, Francis DP (2014) What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? systematic review of randomized placebo-controlled trials to aid individual patient choice. Eur J Prev Cardiol 21:464–474CrossRefPubMedGoogle Scholar
- 20.Liantonio A, Giannuzzi V, Cippone V, Camerino GM, Pierno S, Camerino DC (2007) Fluvastatin and atorvastatin affect calcium homeostasis of rat skeletal muscle fibers in vivo and in vitro by impairing the sarcoplasmic reticulum/mitochondria Ca2+-release system. J Pharmacol Exp Ther 321:626–634CrossRefPubMedGoogle Scholar
- 37.Stone NJ, Robinson JG, Lichtenstein AH, Bairey MCN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SCJ, Watson K, Wilson PW (2014) 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the american college of cardiology/american heart association task force on practice guidelines. Circulation 129:S1–S45CrossRefPubMedGoogle Scholar
- 40.Young JS, Maffuli N (2007) Etiology and epidemiology of Achilles tendon problems. In: Maffuli N, Almekinders LC (eds) The Achilles tendon. Springer, London, pp 39–49Google Scholar